6.30
2.48%
-0.16
前日終値:
$6.46
開ける:
$6.48
24時間の取引高:
168.37K
Relative Volume:
0.73
時価総額:
$255.09M
収益:
$68.68M
当期純損益:
$-60.84M
株価収益率:
-3.913
EPS:
-1.61
ネットキャッシュフロー:
$-38.42M
1週間 パフォーマンス:
+1.61%
1か月 パフォーマンス:
+4.48%
6か月 パフォーマンス:
-21.93%
1年 パフォーマンス:
-43.19%
Pulmonx Corp Stock (LUNG) Company Profile
LUNG を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
LUNG
Pulmonx Corp
|
6.30 | 255.09M | 68.68M | -60.84M | -38.42M | -1.61 |
ABT
Abbott Laboratories
|
118.95 | 208.18B | 41.22B | 5.77B | 6.49B | 2.94 |
SYK
Stryker Corp
|
388.14 | 148.70B | 21.97B | 3.59B | 3.21B | 6.74 |
BSX
Boston Scientific Corp
|
90.75 | 133.32B | 15.91B | 1.79B | 1.89B | 0.82 |
MDT
Medtronic Plc
|
86.27 | 111.27B | 33.00B | 4.29B | 5.50B | 2.71 |
EW
Edwards Lifesciences Corp
|
72.07 | 42.66B | 6.60B | 4.16B | 490.10M | 2.34 |
Pulmonx Corp Stock (LUNG) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2024-06-04 | 開始されました | Lake Street | Buy |
2024-02-23 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
2023-09-05 | 開始されました | Craig Hallum | Buy |
2023-02-27 | アップグレード | Wells Fargo | Equal Weight → Overweight |
2023-01-03 | ダウングレード | BofA Securities | Neutral → Underperform |
2022-12-12 | アップグレード | Citigroup | Neutral → Buy |
2022-07-11 | ダウングレード | Citigroup | Buy → Neutral |
2022-03-02 | 再開されました | BofA Securities | Neutral |
2021-12-08 | アップグレード | Piper Sandler | Neutral → Overweight |
2021-04-01 | 開始されました | Citigroup | Buy |
2021-03-25 | 開始されました | Piper Sandler | Neutral |
2021-03-10 | アップグレード | BofA Securities | Neutral → Buy |
2021-01-04 | ダウングレード | BofA Securities | Buy → Neutral |
2020-10-26 | 開始されました | BofA Securities | Buy |
2020-10-26 | 開始されました | Canaccord Genuity | Buy |
2020-10-26 | 開始されました | Morgan Stanley | Equal-Weight |
2020-10-26 | 開始されました | Stifel | Buy |
2020-10-26 | 開始されました | Wells Fargo | Equal Weight |
すべてを表示
Pulmonx Corp (LUNG) 最新ニュース
Pulmonx (NASDAQ:LUNG) vs. Fractyl Health (NASDAQ:GUTS) Head-To-Head Review - Defense World
Pulmonx director French sells $132,600 in stock - Investing.com
Millrace Asset Group Inc. Purchases Shares of 167,725 Pulmonx Co. (NASDAQ:LUNG) - MarketBeat
Does Pulmonx (LUNG) Have the Potential to Rally 117.74% as Wall Street Analysts Expect? - Yahoo Finance
Pulmonx to Present at the Piper Sandler 36th Annual Healthcare Conference - Yahoo Finance
Pulmonx Partners with American Lung Association to Launch New Educational Initiatives for COPD Patients and Providers - Yahoo Finance
Endobronchial Valve System Market Explosive Growth - openPR
FMR LLC Bolsters Stake in Pulmonx Corp - GuruFocus.com
Morgan Stanley's Strategic Reduction in Pulmonx Corp Holdings - GuruFocus.com
Pulmonx to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum - Yahoo Finance
Wall Street Analysts Predict an 89.61% Upside in Pulmonx (LUNG): Here's What You Should Know - Yahoo Finance
Here's What Analysts Are Forecasting For Pulmonx Corporation (NASDAQ:LUNG) After Its Third-Quarter Results - Yahoo Finance UK
Pulmonx Third Quarter 2024 Earnings: EPS Beats Expectations - Yahoo Finance
Pulmonx Corporation (NASDAQ:LUNG) Q3 2024 Earnings Call Transcript - Insider Monkey
Pulmonx Corp (LUNG) Q3 2024 Earnings Call Highlights: Strong Rev - GuruFocus.com
Earnings call: Pulmonx reports solid growth and strategic advances in Q3 - Investing.com UK
Pulmonx Corp (LUNG) Q3 2024 Earnings: Revenue Hits $20.4M, EPS a - GuruFocus.com
Pulmonx Corp (LUNG) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amidst Strategic ... - Yahoo Finance UK
Pulmonx Corp (LUNG) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amidst Strategic ... By GuruFocus - Investing.com Canada
Pulmonx Corporation (LUNG) Reports Q3 Loss, Misses Revenue Estimates - Yahoo Finance
Pulmonx earnings beat by $0.81, revenue topped estimates - Investing.com
Pulmonx Reports Third Quarter 2024 Financial Results - Yahoo Finance
Pulmonx Co. (NASDAQ:LUNG) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
nVerses Capital LLC Buys Shares of 3,100 Pulmonx Co. (NASDAQ:LUNG) - Defense World
Pulmonx (LUNG) Set to Announce Quarterly Earnings on Wednesday - MarketBeat
Pulmonx director sells $130,399 in common stock By Investing.com - Investing.com South Africa
Pulmonx director sells $130,399 in common stock - Investing.com India
Pulmonx to Report Third Quarter 2024 Financial Results on October 30, 2024 - Yahoo Finance
Millennium Management LLC Lowers Stock Position in Pulmonx Co. (NASDAQ:LUNG) - MarketBeat
Point72 Asia Singapore Pte. Ltd. Makes New Investment in Pulmonx Co. (NASDAQ:LUNG) - Defense World
Squarepoint Ops LLC Acquires 104,432 Shares of Pulmonx Co. (NASDAQ:LUNG) - MarketBeat
Pulmonx Co. (NASDAQ:LUNG) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Point72 Asset Management L.P. Sells 2,474,183 Shares of Pulmonx Co. (NASDAQ:LUNG) - MarketBeat
Point72 Asia Singapore Pte. Ltd. Takes $37,000 Position in Pulmonx Co. (NASDAQ:LUNG) - Defense World
Phunware (NASDAQ:PHUN) Stock Price Up 4.2% - Defense World
PulteGroup Inc [PHM] Insider FOLLIARD THOMAS J sells 19,000 Shares – Latest News - Knox Daily
Urban Outfitters, Inc. (NASDAQ:URBN) Shares Sold by Shapiro Capital Management LLC - Defense World
Market Recap: Trupanion Inc (TRUP)’s Positive Momentum, Closing at 42.80 - The Dwinnex
Bank of New York Mellon Corp Purchases 17,740 Shares of Pulmonx Co. (NASDAQ:LUNG) - Defense World
PulteGroup, Inc. (NYSE:PHM) Shares Sold by MQS Management LLC - Defense World
Trupanion (NASDAQ:TRUP) Given New $45.00 Price Target at Northland Securities - Defense World
Texas Permanent School Fund Corp Has $1.08 Million Stake in Trupanion, Inc. (NASDAQ:TRUP) - Defense World
Intech Investment Management LLC Purchases 133,283 Shares of PulteGroup, Inc. (NYSE:PHM) - Defense World
Waterloo Capital L.P. Sells 223 Shares of PulteGroup, Inc. (NYSE:PHM) - Defense World
Trupanion (NASDAQ:TRUP) Shares Gap Up on Analyst Upgrade - MarketBeat
Pulmonx director French Glendon E. III sells $161,800 in company stock - Investing.com Australia
Glendon E. French III Sells 20,000 Shares of Pulmonx Co. (NASDAQ:LUNG) Stock - Defense World
Pulmonx Co. (NASDAQ:LUNG) Receives Average Recommendation of “Moderate Buy” from Brokerages - Defense World
Pulmonx Announces Presentation of Clinical Data from the AeriSeal® CONVERT Trial and 5-Year Follow-up Data from the LIBERATE Study at the European Respiratory Society Congress 2024 - Yahoo Finance
Pulmonx executive sells over $30,000 in company stock - Investing.com India
Pulmonx corp general counsel sells over $38k in company stock - Investing.com
Pulmonx Corp (LUNG) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):